Cannabis Science Inc. Announces Advances In Its Analytical Lab Logistics

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science Inc. (NASD OTCBB: CBIS), a pharmaceutical cannabis company in the US, is pleased to announce progress in its Analytical Lab Division at Cannabis Science. Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., explained, " As a patient oriented company located in a state with effective medical marijuana laws, we are able to study the medical production and use of cannabis in a variety of modalities. At the core of this research, we are working with patients producing top grade medical cannabis as the starting point for extracts and formulations to treat the many disease states that cannabinoids positively impact. Efficient, stable propagation and quality control of the starting material and downstream processes are essential to this progress." There are several integral and interdependent facets of this approach:

Back to news